Diabetes – already prevalent worldwide, its incidence is expected to continue to grow exponentially in the coming years. This disease in which the body fails to produce or respond appropriately to the insulin hormone manifests in two types: type 1 and type 2, and if untreated, results in dangerously elevated glucose levels in the blood and urine. Prolonged hyperglycemia (high blood sugar) can lead to serious complications, including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers.
Follow the latest developments in diabetes with detailed market reports, forecasts, analysis, and more.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726